Author:
Rivera-Valentin Rocio K.,Zhu Limin,Hughes Dennis P. M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pediatrics, Perinatology and Child Health
Reference183 articles.
1. Cheng YY, Huang L, Lee KM, Li K, Kumta SM. Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines. Pediatr Blood Cancer. 2004;42(5):410–5 (Epub 2004/03/30).
2. Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev. 2014;40(4):523–32.
3. Janeway KA, Grier HE. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol. 2010;11(7):670–8.
4. Sybil Biermann J, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Butrynski JE, et al. Bone cancer: clinical practice guidelines in oncology. JNCCN. 2013;11(6):688–723.
5. Whelan J, Seddon B, Perisoglu M. Management of osteosarcoma. Curr Treat Options Oncol. 2006;7(6):444–55.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献